Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Landesbank Baden Wurttemberg

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$251M
Portfolio companies 7
Rounds per year 0.04
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 4
Key employees Soon

Areas of investment

  • Software
  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • 3D Technology
Summary

In 1818 was created Landesbank Baden Wurttemberg, which is appeared as Corporate Investor. The company was established in Europe in Germany. The leading representative office of defined Corporate Investor is situated in the Stuttgart.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are SaaS, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight BrandMaker. Besides, a startup needs to be aged 16-20 years to get the investment from the fund.

The top activity for fund was in 2018. Comparing to the other companies, this Landesbank Baden Wurttemberg performs on 4 percentage points more the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.

The standard case for the fund is to invest in rounds with 3 partakers. Despite the Landesbank Baden Wurttemberg, startups are often financed by eCAPITAL entrepreneurial Partners AG, Nextech Invest, S-Kap Unternehmensbeteiligungs. The meaningful sponsors for the fund in investment in the same round are Future Capital, eCAPITAL entrepreneurial Partners AG, VI Partners AG. In the next rounds fund is usually obtained by Future Capital, MIG AG, VI Partners AG.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Landesbank Baden Wurttemberg:
Typical Co-investors
Landesbank Baden Wurttemberg is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Landesbank Baden Wurttemberg:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Adani Ports Ahmedabad, Gujarat, India
Black Fish China, Jiangsu, Nanjing
Blockchain Ventures California, Palo Alto, United States
Direct Line Insurance Bromley, England, United Kingdom
Dolma Impact Fund Ebène, Mauritius, Plaines Wilhems
French IoT -
Haddad Advisory -
Herrikoa Anglet, Aquitaine, France
JBV Capital California, San Francisco, United States
Lanai Partners Barcelona, Catalonia, Spain
Maxim Group New York, New York, United States
One Mind Brain Health Impact Fund -
Portage Partners New York, New York, United States
Rowny Capital District of Columbia, United States, Washington
Sprint Kansas, Overland Park, United States
Sutardja Ventures -
TSARI Capital -
UK Innovation & Science Seed Fund Harwell, Oxfordshire, United Kingdom
Winrock International Arkansas, Little Rock, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Swiat

Blockchain
Cryptocurrency
Financial Services
FinTech
Software
26 Jan 2023 Frankfort, Maine, United States

3D Printing
3D Technology
Enterprise Software
Industrial Manufacturing
Manufacturing
Software
$6M22 Apr 2021 Berlin, Berlin, Germany

BrandMaker

Application Software
Brand Marketing
Business/Productivity Software
Content Marketing
Digital Marketing
Information Technology
Marketing
Media and Information Services (B2B)
SaaS
Software
27 Jun 2018 Atlanta, Georgia, United States

Ganymed Pharmaceuticals

Biopharma
Biotechnology
Pharmaceutical
$39M24 Sep 2007 Mainz, Rhineland-Palatinate, Germany

Ganymed Pharmaceuticals

Biopharma
Biotechnology
Pharmaceutical
$14M06 Jul 2005 Mainz, Rhineland-Palatinate, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Landesbank Baden Wurttemberg?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 251M
Rounds per year 0.04
Peak activity year 2023
Lead investments 0
Follow on index 0.12
Exits 4
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Swiat

Blockchain
Cryptocurrency
Financial Services
FinTech
Software
26 Jan 2023 Frankfort, Maine, United States

3D Printing
3D Technology
Enterprise Software
Industrial Manufacturing
Manufacturing
Software
$6M22 Apr 2021 Berlin, Berlin, Germany

BrandMaker

Application Software
Brand Marketing
Business/Productivity Software
Content Marketing
Digital Marketing
Information Technology
Marketing
Media and Information Services (B2B)
SaaS
Software
27 Jun 2018 Atlanta, Georgia, United States

Ganymed Pharmaceuticals

Biopharma
Biotechnology
Pharmaceutical
$39M24 Sep 2007 Mainz, Rhineland-Palatinate, Germany

Ganymed Pharmaceuticals

Biopharma
Biotechnology
Pharmaceutical
$14M06 Jul 2005 Mainz, Rhineland-Palatinate, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: